SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017001
Filing Date
2023-05-15
Accepted
2023-05-15 10:00:44
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 479208
2 ex31-1.htm EX-31.1 12341
3 ex31-2.htm EX-31.2 12402
4 ex32-1.htm EX-32.1 11443
5 f10-q_001.jpg GRAPHIC 89463
6 f10-q_002.jpg GRAPHIC 45392
7 image_006.jpg GRAPHIC 7013
  Complete submission text file 0001493152-23-017001.txt   3218702

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcsa-20230331.xsd EX-101.SCH 26790
9 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcsa-20230331_cal.xml EX-101.CAL 35951
10 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcsa-20230331_def.xml EX-101.DEF 106263
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcsa-20230331_lab.xml EX-101.LAB 231239
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcsa-20230331_pre.xml EX-101.PRE 182674
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 263413
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39531 | Film No.: 23919253
SIC: 2834 Pharmaceutical Preparations